References
Cimolai N, Morrison BJ, Carter JE (1992) Risk factors for the central nervous system manifestations of gastroenteritis associated hemolytic uremic syndrome. Pediatrics 90: 616–621
Fujii J, Kita T, Yoshida S, Takeda T, Kobayashi H, Tanaka N, Ohsato K, Mizuguchi Y (1994) Direct evidence of neuron impairment by oral infection with Shigatoxin-producing Escherichia coli O157:H in mitomycin treated mice. Infect Immun 62: 3447–3453
Fujii J, Kinoshita Y, Kita T, Higure A, Takeda T, Tanaka N, Yoshida S (1996) Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous Shigatoxin 2. Infect Immun 64: 5053–5060
Hamano S, Nakanishi Y, Nara T, Seki T, Ohtani T, Oishi T, Joh K, Oikawa T, Muramatsu Y, Ogawa Y, Akashi S (1993) Neurological manifestation of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan. Acta Paedatr 82: 454–458
Karch H, Huppertz HI, Bockemühl J, Schmidt H, Schwarzkopf A, Lissner R (1997) Shiga toxin-producing Escherichia coli infections in Germany. J Food Prot 60: 1454–1457
Ludwig K, Sarkim V, Karmali MA, Bitzan M, Bobrowski C, Ruder H, Sobottka I, Laufs R, Petric M, Karch H, Müller-Wiefel DE and Arbeitsgemeinschaft für Pädiatrische Nephrologie (2001) Immunoreaction to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic uremic syndrome. J Clin Microbiol 39: 2272–2279
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahrens, F., Ludwig, K., Terstegge, K. et al. Encephalopathy and exposure to Shiga toxin without evidence of haemolytic uraemic syndrome. Eur J Pediatr 161, 462–463 (2002). https://doi.org/10.1007/s00431-002-0988-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-002-0988-7